Showing results (1-10 of 262) with videos related to
Sort By:
Pageof 27
Clinics in Colon and Rectal Surgery|May 4, 2018
Colorectal Cancer in Inflammatory Bowel DiseaseRyan W Stidham, Peter D R HigginsExpert Review of Gastroenterology & Hepatology|June 10, 2010
Value of mucosal assessment and biomarkers in inflammatory bowel diseaseRyan W Stidham, Peter D R HigginsInflammatory Bowel Diseases|April 19, 2018
Predicting Corticosteroid-Free Biologic Remission with Vedolizumab in Crohn's DiseaseAkbar K Waljee, Boang Liu, Kay Sauder, et al.Gastroenterology & Hepatology|November 15, 2023
Bringing the Inflamed and Fibrotic Bowel into Focus: Imaging in Inflammatory Bowel DiseaseJeremy Adler, Ryan W Stidham, Peter D R HigginsJournal of Crohn'S & Colitis|July 25, 2013
How early to take arms against a sea of troubles? The case for aggressive early therapy in Crohn's disease to prevent fibrotic intestinal stricturesShail M Govani, Ryan W Stidham, Peter D R HigginsJAMA Network Open|May 11, 2019
Development and Validation of Machine Learning Models in Prediction of Remission in Patients With Moderate to Severe Crohn DiseaseAkbar K Waljee, Beth I Wallace, Shirley Cohen-Mekelburg, et al.Journal of Crohn'S & Colitis|March 24, 2017
Machine Learning Algorithms for Objective Remission and Clinical Outcomes with ThiopurinesAkbar K Waljee, Kay Sauder, Anand Patel, et al.Therapeutic Advances in Gastroenterology|March 10, 2023
Vedolizumab more likely to be discontinued than ustekinumab in anti-TNF-experienced patients with fistulizing Crohn's diseaseKira L Newman, Laura A Johnson, Ryan W Stidham, et al.Plos One|January 24, 2017
Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's DiseaseRyan W Stidham, Jing Wu, Jiaqi Shi, et al.Plos One|March 30, 2018
CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospitalShail M Govani, Peter D R Higgins, Joel H Rubenstein, et al.Pageof 27